Cargando…
IL-2 complex recovers steroid-induced inhibition in immunochemotherapy for head and neck cancer
Background: A combination therapy with immune checkpoint inhibitors (ICIs) and platinum-based chemotherapy has become the first-line treatment for recurrent or metastatic head and neck squamous carcinoma (HNSCC). Although steroids are often used as anti-emetic medications during chemotherapy, their...
Autores principales: | Kono, Michihisa, Yamaki, Hidekiyo, Komatsuda, Hiroki, Kumai, Takumi, Hayashi, Ryusuke, Wakisaka, Risa, Sato, Ryosuke, Ohara, Kenzo, Kishibe, Kan, Takahara, Miki, Katada, Akihiro, Hayashi, Tatsuya, Harabuchi, Yasuaki |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8819385/ https://www.ncbi.nlm.nih.gov/pubmed/35123188 http://dx.doi.org/10.1016/j.tranon.2022.101358 |
Ejemplares similares
-
Immunomodulation via FGFR inhibition augments FGFR1 targeting T-cell based antitumor immunotherapy for head and neck squamous cell carcinoma
por: Kono, Michihisa, et al.
Publicado: (2022) -
Antitumor Peptide-Based Vaccine in the Limelight
por: Kumai, Takumi, et al.
Publicado: (2022) -
Mitogen‐activated protein kinase inhibition augments the T cell response against HOXB7‐expressing tumor through human leukocyte antigen upregulation
por: Komatsuda, Hiroki, et al.
Publicado: (2022) -
The efficacy of PD‐1 inhibitors in patients with salivary gland carcinoma: A retrospective observational study
por: Sato, Ryosuke, et al.
Publicado: (2022) -
Expression of placenta-specific 1 and its potential for eliciting anti-tumor helper T-cell responses in head and neck squamous cell carcinoma
por: Hayashi, Ryusuke, et al.
Publicado: (2020)